BTC $63,022.55 -0.05%
ETH $1,879.43 -0.16%
BNB $605.39 -0.89%
XRP $1.00 -0.47%
SOL $75.40 -0.09%
TRX $0.3307 -0.54%
DOGE $0.0697 -0.74%
ADA $0.1767 -2.04%
BCH $202.98 -1.37%
LINK $9.38 -0.90%
HYPE $57.08 +1.56%
AAVE $86.26 -0.87%
SUI $0.6755 -1.41%
XLM $0.1567 -1.51%
ZEC $486.95 -1.25%
BTC $63,022.55 -0.05%
ETH $1,879.43 -0.16%
BNB $605.39 -0.89%
XRP $1.00 -0.47%
SOL $75.40 -0.09%
TRX $0.3307 -0.54%
DOGE $0.0697 -0.74%
ADA $0.1767 -2.04%
BCH $202.98 -1.37%
LINK $9.38 -0.90%
HYPE $57.08 +1.56%
AAVE $86.26 -0.87%
SUI $0.6755 -1.41%
XLM $0.1567 -1.51%
ZEC $486.95 -1.25%

The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

app_icon
ChainCatcher Building the Web3 world with innovations.